Evidence map›Paper›PMID 35562919›Full record

ArticleInternational journal of molecular sciences2022

Alleviation of Endoplasmic Reticulum Stress Enhances Human Corneal Epithelial Cell Viability under Hyperosmotic Conditions.

Damien Guindolet, Ashley M Woodward, Eric E Gabison, Pablo Argüeso

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Damien GuindoletSchepens Eye Research Institute of Mass. Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford St., Boston, MA 02114, USA.
Ashley M WoodwardSchepens Eye Research Institute of Mass. Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford St., Boston, MA 02114, USA.ORCID 0000-0003-4045-8123
Eric E GabisonHôpital Fondation A. de Rothschild, 25 rue Manin, 75019 Paris, France.
Pablo ArgüesoSchepens Eye Research Institute of Mass. Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford St., Boston, MA 02114, USA.ORCID 0000-0001-7321-9503
Massachusetts Eye and Ear Infirmary · USUniversité Paris Cité · FR

Funding

N-Glycosylation and Ocular Surface HomeostasisR01EY026147 · NEI · TUFTS MEDICAL CENTER · PI Pablo Argueso · 2016 to 2026
$5.1M
NEI NIH HHS R01 EY026147NEI NIH HHS R01EY026147
6 · The paper itself

Abstract

Tear hyperosmolarity plays an essential role in the initiation and progression of dry-eye disease. Under a hyperosmotic environment, corneal epithelial cells experience perturbations in endoplasmic reticulum function that can lead to proinflammatory signaling and apoptosis. In this study, we investigated the effect of tauroursodeoxycholic acid (TUDCA), a chemical chaperone known to protect against endoplasmic reticulum stress, on corneal epithelial cells exposed to hyperosmotic conditions. We found that the expression of the genes involved in the activation of the unfolded protein response and the pro-apoptotic transcription factor

Indexed as

Dry Eye SyndromesEndoplasmic Reticulum StressApoptosisEpithelial CellsHumansTaurochenodeoxycholic AcidUnfolded Protein ResponseTaurochenodeoxycholic Acidcorneal epitheliumdry eyeendoplasmic reticulum stresshyperosmotic stresstauroursodeoxycholic acidunfolded protein response

Identifiers

PMID35562919
PMCPMC9104051
OpenAlexW3139525502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.